Northern Trust
DTIL icon

Northern Trust’s Precision BioSciences DTIL Stock Holding History

Northern Trust’s Portfolio DTIL Stock Details DTIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$418K Sell
76,069
-10,395
-12% -$48K ﹤0.01% 3684
2025
Q4 		$360K Buy
86,464
+48,397
+127% +$275K ﹤0.01% 3774
2025
Q3 		$210K Sell
38,067
-2,260
-6% -$10.8K ﹤0.01% 3964
2025
Q2 		$169K Sell
40,327
-2,700
-6% -$13.3K ﹤0.01% 3991
2025
Q1 		$205K Buy
43,027
+5,951
+16% +$30.3K ﹤0.01% 3936
2024
Q4 		$141K Sell
37,076
-234
-0.6% -$1.71K ﹤0.01% 4083
2024
Q3 		$334K Buy
37,310
+26,922
+259% +$259K ﹤0.01% 3699
2024
Q2 		$101K Buy
+10,388
New +$122K ﹤0.01% 4048
2024
Q1 		– Sell
-5,231
Closed -$57.3K – 4437
2023
Q4 		$57.3K Hold
5,231
– – ﹤0.01% 4214
2023
Q3 		$53.6K Hold
5,231
– – ﹤0.01% 4150
2023
Q2 		$82.5K Sell
5,231
-424
-7% -$9.69K ﹤0.01% 4086
2023
Q1 		$128K Sell
5,655
-470
-8% -$15.5K ﹤0.01% 4017
2022
Q4 		$219K Buy
6,125
+1,422
+30% +$56.2K ﹤0.01% 3827
2022
Q3 		$183K Buy
4,703
+818
+21% +$38.9K ﹤0.01% 3909
2022
Q2 		$186K Sell
3,885
-12,589
-76% -$739K ﹤0.01% 3965
2022
Q1 		$1.52M Sell
16,474
-744
-4% -$101K ﹤0.01% 3237
2021
Q4 		$3.82M Sell
17,218
-41
-0.2% -$11.5K ﹤0.01% 2857
2021
Q3 		$5.97M Sell
17,259
-268
-2% -$90.8K ﹤0.01% 2618
2021
Q2 		$6.58M Buy
17,527
+1,021
+6% +$307K ﹤0.01% 2662
2021
Q1 		$5.13M Sell
16,506
-717
-4% -$251K ﹤0.01% 2724
2020
Q4 		$4.31M Sell
17,223
-424
-2% -$104K ﹤0.01% 2768
2020
Q3 		$3.26M Buy
17,647
+1,465
+9% +$291K ﹤0.01% 2788
2020
Q2 		$4.04M Buy
16,182
+4,060
+33% +$889K ﹤0.01% 2643
2020
Q1 		$2.19M Buy
12,122
+26
+0.2% +$6.81K ﹤0.01% 2802
2019
Q4 		$5.04M Buy
12,096
+8,093
+202% +$2.54M ﹤0.01% 2578
2019
Q3 		$1.01M Buy
4,003
+2,555
+176% +$832K ﹤0.01% 3394
2019
Q2 		$575K Buy
+1,448
New +$583K ﹤0.01% 3519

Other funds holding DTIL

OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
EAM
Empery Asset Management New York $83M AUM
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Northern Trust's DTIL Position: Q1 2026 in Review

Northern Trust reduced its Precision BioSciences (DTIL) stake by 12% in Q1 2026, selling an estimated $48K and leaving 76,069 shares worth $418K. The position accounts for ﹤0.01% of the portfolio, ranked #3684.

Northern Trust first reported a position in DTIL in Q2 2019 and has held it in 27 quarters since. The position peaked at $6.58M in Q2 2021. 78 funds tracked by Wall St. Rank hold DTIL as of Q1 2026.

  • Northern Trust held 76,069 shares of Precision BioSciences worth $418K as of Q1 2026.
  • Northern Trust sold 10,395 Precision BioSciences shares in Q1 2026, an estimated $48K.
  • Precision BioSciences made up ﹤0.01% of Northern Trust's portfolio in Q1 2026, its #3684 holding.
  • Northern Trust first reported a position in Precision BioSciences in Q2 2019 and has held it in 27 quarters since.
  • Northern Trust's Precision BioSciences position peaked at $6.58M in Q2 2021.
  • 78 funds tracked by Wall St. Rank held Precision BioSciences as of Q1 2026.

Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.